Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Status:
RECRUITING
Trial end date:
2026-10-18
Target enrollment:
Participant gender:
Summary
This study is a multicenter, randomized, double-blind, parallel, placebo-controlled trial design to evaluate the efficacy and safety of the KPCXM18 injection at different doses for the treatment of acute ischemic stroke.